Journey Medical (DERM) Interest & Investment Income (2022 - 2026)
Journey Medical's (DERM) quarterly Interest & Investment Income came in at $154000.0 in Q2 2026, up 11.59% on a YoY basis from $138000.0 in Q2 2025, and down 1.91% quarter-over-quarter from $157000.0 in Q1 2026.
Powered by 
Analysis
Journey Medical (DERM) Interest & Investment Income (2022 - 2026) Analysis & Trends
Journey Medical (DERM) has reported Interest & Investment Income for 5 consecutive years, with $154000.0 the latest figure, recorded in Q2 2026.
- For the quarter ending Q2 2026, Interest & Investment Income rose 11.59% year-over-year to $154000.0; the trailing twelve-month figure through Jun 2026 stood at $613000.0 (down 7.96% YoY), and the FY2025 full-year result was $589000.0, down 22.19% from the prior year.
- Interest & Investment Income slipped to $154000.0 in Q2 2026 per DERM's latest filing, from $157000.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $217000.0 in Q1 2024 and bottomed at $3000.0 in Q1 2022.
- Historically, Interest & Investment Income has averaged $113277.8 across 5 years, with a median of $143000.0 in 2025.
- The sharpest annual moves came in 2023 and 2025: Interest & Investment Income soared 3966.67% in 2023, then plunged 31.34% in 2025.
- Over 5 years, Interest & Investment Income stood at $50000.0 in 2022, then soared by 126.0% to $113000.0 in 2023, then surged by 69.03% to $191000.0 in 2024, then dropped by 22.51% to $148000.0 in 2025, then gained by 4.05% to $154000.0 in 2026.
- According to Business Quant data, Interest & Investment Income over the past three periods registered $154000.0, $157000.0, and $148000.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 642.70 Bn | 621.95 Bn | 17.26 Bn | 219.00 Mn |
| 2 | AbbVie | 440.80 Bn | 434.23 Bn | 12.70 Bn | -679.00 Mn |
| 3 | Merck | 364.74 Bn | 357.60 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 266.37 Bn | 258.68 Bn | 11.24 Bn | - |
| 5 | Pfizer | 158.89 Bn | 147.19 Bn | 10.94 Bn | - |
| 6 | Sanofi | 52.43 Bn | 45.05 Bn | 10.79 Bn | 89.50 Mn |
| 7 | Revolution Medicines | 44.38 Bn | 44.38 Bn | - | 35.58 Mn |
| 8 | Incyte | 25.28 Bn | 20.74 Bn | 1.57 Bn | 38.12 Mn |
| 9 | United Therapeutics | 21.46 Bn | 18.80 Bn | 683.80 Mn | 31.50 Mn |
| 10 | Journey Medical | 210.60 Mn | 184.96 Mn | 12.37 Mn | 154,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 154,000.00 |
| Mar 31, 2026 | 157,000.00 |
| Dec 31, 2025 | 148,000.00 |
| Sep 30, 2025 | 154,000.00 |
| Jun 30, 2025 | 138,000.00 |
| Mar 31, 2025 | 149,000.00 |
| Dec 31, 2024 | 191,000.00 |
| Sep 30, 2024 | 188,000.00 |
| Jun 30, 2024 | 161,000.00 |
| Mar 31, 2024 | 217,000.00 |
| Dec 31, 2023 | 113,000.00 |
| Sep 30, 2023 | 8,000.00 |
| Jun 30, 2023 | 79,000.00 |
| Mar 31, 2023 | 122,000.00 |
| Dec 31, 2022 | 50,000.00 |
| Sep 30, 2022 | 3,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 3,000.00 |